Category: Uncategorized

Spirituality and Perinatal bulletins available

Please find available the latest Spirituality and Mental Health and Perinatal Mental Health bulletins, produced by Greater Manchester Mental Health Trust.

If you are unable to access any of the articles please contact academic.library@lscft.nhs.uk.

Eating Disorders and EMDR bulletins available

Please find the latest Eating Disorders and Eye Movement Desensitisation and Reprocessing (EMDR) bulletins produced by Greater Manchester Mental Health Trust. If you have difficulties accessing any of the articles please contact the library on academic.library@lscft.nhs.uk.

Is Psychiatry Working?

If you missed the BBC radio 4 series Is Psychiatry Working? it is available on BBC Sounds and an intriguing listen. Writer Horatio Clare (who himself had a breakdown a few years ago) and psychiatrist Professor Femi Oyebode discuss the issues and concerns around crisis, detention, diagnosis, medication, therapy and healing and recovery.

Is Psychiatry Working? – Crisis – BBC Sounds

Forensic Psychiatry and Rehabilitation and Recovery bulletins

Please find the latest Forensic Psychiatry and Rehabilitation and Recovery bulletins produced by Greater Manchester Mental Health Trust. If you have difficulties accessing any of the articles please contact the library on academic.library@lscft.nhs.uk.

Do you use grey literature? Health Education England need your help!

Health Education England is carrying out a survey into NHS library and knowledge service users’ use of grey literature. Do you routinely use source materials that are not published in journals (example unpublished research, conference papers, service evaluation reports, government documents, posters and QI projects) or do you actively avoid them? Fil in the survey to help Health Education England know what you use and need from such resources.

US research suggests slowing, not stopping, Alzheimer’s should be the goal for clinical drug trials

Slowing progression of, rather than stopping, Alzheimer’s disease has measurable benefits for patients and families and may be a more realistic goal for clinical drug trials, a new report by the American Alzheimer’s Association has suggested.

The report‘s authors call for a “reframing” of how researchers define “clinically meaningful” in randomized controlled trials, adding that they consider it is time to adjust expectations of outcomes from relatively short clinical trials.

The report was published by an expert work group convened by the Alzheimer’s Association. It was prompted, in part, by the US Food and Drug Administration’s controversial decision to grant aducanumab (Aduhelm) accelerated approval, which came over the objection of an advisory panel that found the drug was ineffective.

Slowing, Not Stopping, Alzheimer’s a Better Goal for Drug Trials? (medscape.com)